Genotype distribution and behavioral risk factor analysis of human papillomavirus infection in uyghur women

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5861-5865

  Sui, Shuang ^a   Jiao, Zhen ^b   Niyazi, Mayinuer ^b   Sulaiya, ^b   Lu, Ping ^b   Qiao, You Lin ^c  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b People's Hospital of Xinjiang Uyghur Autonomous Region   (China)

^c CANCER HOSPITAL   (China)

Author keywords

Genotypes distribution; Human papillomavirus; Risk factors; Uyghur women

Indexed keywords

VIRUS DNA;

ADULT; CHINA; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; VIROLOGY; YOUNG ADULT;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; WOMEN; YOUNG ADULT;

EID: 84890477875     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5861     Document Type: Article

References (27)

1. Arbyn M, Castellsague X, de Sanjose S, et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, 22, 2675-86.
2. Arbyn M, Walker A, Meijer CJ (2010). HPV-based cervicalcancer screening in China. Lancet Oncol, 11, 1112-3.
3. Bao YP, Li N, Smith JS, Qiao YL (2008). Human papillomavirus type-distribution in the cervix of Chinese women: A metaanalysis. Int J STD AIDS, 19, 106-11.
4. Boccalini S, Tiscione E, Bechini A, et al (2012). Sexual behavior, use of contraceptive methods and risk factors for HPV infections of students living in central Italy: Implications for vaccination strategies. J Prev Med Hyg, 53, 24-9.
5. Cokkinides VE, Bandi P, Siegel RL, Jemal A (2012). Cancerrelated risk factors and preventive measures in US Hispanics/Latinos. CA Cancer J Clin, 62, 353-63.
6. Confortini M, Carozzi F, Zappa M, et al (2010). Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: Results at recruitment. BMC Infect Dis, 10, 157.
7. de Sanjose S, Diaz M, Castellsague X, et al (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis, 7, 453-9.
8. De Vuyst H, Ndirangu G, Moodley M, et al (2012). Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer, 131, 949-55.
9. Faust H, Jelen MM, Poljak M, et al (2013). Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types. J Clin Virol, 56, 336-41.
10. Guan P, Howell-Jones R, Li N, et al (2012). Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer, 131, 2349-59.
11. Guerry SL, De Rosa CJ, Markowitz LE, et al (2011). Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine, 29, 2235-41.
12. Guzalinuer A, Chen JX (2007). The spectrum of HPV infection in Xinjiang Uyghur women with cervical cancer. Tumor, 27, 379-82.
13. Guzhalinuer A, Chen JX, Mick R (2007). HPV spectroscopy study of Xinjiang Uyghur cancer women. Tumor, 2007, 329-82.
14. Hogewoning CJ, Bleeker MC, van den Brule AJ, et al (2003). Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial. Int J Cancer, 107, 811-6.
15. Murphy J, Mark H (2012). Cervical cancer screening in the era of human papillomavirus testing and vaccination. J Midwifery Womens Health, 57, 569-76.
16. Nam K, Kwak J, Kim J, Jeon S (2013). Human papillomavirus type 16 causes larger colposcopic lesions than other HPV types in patients with grade 3 cervical intraepithelial neoplasia. J Low Genit Tract Dis, 17, 1-5.
17. Pandey S, Mishra M, Chandrawati (2012). Human papillomavirus screening in north Indian women. Asian Pac J Cancer Prev, 13, 2643-6.
18. Peralta-Rodriguez R, Romero-Morelos P, Villegas-Ruiz V, et al (2012). Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis. Infect Agent Cancer, 7, 34.
19. Quek SC, Lim BK, Domingo E, et al (2013). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia. Int J Gynecol Cancer, 23, 148-56.
20. Rana MM, Huhtala H, Apter D, et al (2013). Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up. Int J Cancer, 132, 2833-8.
21. Raychaudhuri S, Mandal S (2012). Socio-demographic and behavioural risk factors for cervical cancer and knowledge, attitude and practice in rural and urban areas of North Bengal, India. Asian Pac J Cancer Prev, 13, 1093-6.
22. Sanchez-Lander J, Cortinas P, Loureiro CL, et al (2012). Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a crosssectional study. Cancer Epidemiol, 36, e284-7.
23. Sharma M, Bruni L, Diaz M, et al (2013). Using HPV prevalence to predict cervical cancer incidence. Int J Cancer, 132, 1895-900.
24. Siriaunkgul S, Utaipat U, Suwiwat S, et al (2012). Prognostic value of HPV18 DNA viral load in patients with early-stage neuroendocrine carcinoma of the uterine cervix. Asian Pac J Cancer Prev, 13, 3281-5.
25. Velicer C, Zhu X, Vuocolo S, Liaw KL, Saah A (2009). Prevalence and incidence of HPV genital infection in women. Sex Transm Dis, 36, 696-703.
26. Wang L, Dai SZ, Chu HJ, Cui HF, Xu XY (2013). Integration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia. Asian Pac J Cancer Prev, 14, 3837-41.
27. Zou L, Bao YP, Li N, et al (2011). Life-style and genital human papillomavirus in a cross-sectional survey in Shanxi Province, China. Asian Pac J Cancer Prev, 12, 781-6.